Research Solutions (RSSS) 10-Q 14 Nov 16 2017 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Sep. 30, 2016	Nov. 09, 2016
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2016
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q1
Entity Registrant Name	Research Solutions, Inc.
Entity Central Index Key	1,386,301
Current Fiscal Year End Date	--06-30
Entity Filer Category	Smaller Reporting Company
Trading Symbol	RSSS
Entity Common Stock, Shares Outstanding		23,887,723

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2016	Jun. 30, 2016
Current assets:
Cash and cash equivalents	$ 6,566,214	$ 6,076,875
Accounts receivable, net of allowance of $47,635 and $52,084, respectively	4,577,150	5,761,860
Prepaid expenses and other current assets	150,918	164,610
Prepaid royalties	418,065	173,665
Total current assets	11,712,347	12,177,010
Other assets:
Property and equipment, net of accumulated depreciation of $654,177 and $642,051, respectively	78,866	82,207
Intangible assets, net of accumulated amortization of $564,480 and $546,679, respectively	92,256	104,848
Deposits and other assets	7,544	7,594
Total assets	11,891,013	12,371,659
Current liabilities:
Accounts payable and accrued expenses	5,316,477	5,690,768
Deferred revenue	871,367	639,834
Total current liabilities	6,187,844	6,330,602
Commitments and contingencies
Stockholders' equity:
Preferred stock; $0.001 par value; 20,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock; $0.001 par value; 100,000,000 shares authorized; 23,887,723 and 23,809,593 shares issued and outstanding, respectively	23,888	23,810
Additional paid-in capital	21,718,746	21,642,763
Accumulated deficit	(15,992,961)	(15,582,295)
Accumulated other comprehensive loss	(46,504)	(43,221)
Total stockholders' equity	5,703,169	6,041,057
Total liabilities and stockholders' equity	$ 11,891,013	$ 12,371,659

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets [Parenthetical] - USD ($)	Sep. 30, 2016	Jun. 30, 2016
Allowance for Doubtful Accounts Receivable, Current	$ 47,635	$ 52,084
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	654,177	642,051
Finite-Lived Intangible Assets, Accumulated Amortization	$ 564,480	$ 546,679
Preferred Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	20,000,000	20,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	100,000,000	100,000,000
Common Stock, Shares, Issued	23,887,723	23,809,593
Common Stock, Shares, Outstanding	23,887,723	23,809,593

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss) - USD ($)	3 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Revenue	$ 7,658,716	$ 8,027,101
Cost of revenue	6,129,319	6,472,754
Gross profit	1,529,397	1,554,347
Operating expenses:
Selling, general and administrative	1,897,699	1,704,961
Depreciation and amortization	30,469	14,738
Total operating expenses	1,928,168	1,719,699
Loss from operations	(398,771)	(165,352)
Other income (expenses):
Interest expense	(3,000)	(4,993)
Other income	4,710	2,769
Total other income (expenses)	1,710	(2,224)
Loss from operations before provision for income taxes	(397,061)	(167,576)
Provision for income taxes	(13,605)	(11,244)
Discontinued operations:
Net loss	(410,666)	(178,820)
Other comprehensive income (loss):
Foreign currency translation	(3,283)	1,703
Comprehensive loss	$ (413,949)	$ (177,117)
Loss per common share:
Net loss per share, basic and diluted	$ (0.02)	$ (0.01)
Weighted average common shares outstanding, basic and diluted	23,131,570	17,564,070

Condensed Consolidated Stateme5

Condensed Consolidated Statement of Stockholders' Equity - 3 months ended Sep. 30, 2016 - USD ($)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income [Member]
Balance at Jun. 30, 2016	$ 6,041,057	$ 23,810	$ 21,642,763	$ (15,582,295)	$ (43,221)
Balance (in shares) at Jun. 30, 2016		23,809,593
Fair value of vested stock options	14,856	$ 0	14,856	0	0
Fair value of vested restricted common stock	87,733	$ 103	87,630	0	0
Fair value of vested restricted common stock (in shares)		103,638
Repurchase of common stock	(26,528)	$ (25)	(26,503)	0	0
Repurchase of common stock (in shares)		(25,508)
Net loss for the period	(410,666)	$ 0	0	(410,666)	0
Foreign currency translation	(3,283)	0	0	0	(3,283)
Balance at Sep. 30, 2016	$ 5,703,169	$ 23,888	$ 21,718,746	$ (15,992,961)	$ (46,504)
Balance (in shares) at Sep. 30, 2016		23,887,723

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Cash flow from operating activities:
Net loss	$ (410,666)	$ (178,820)
Adjustment to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	30,469	14,738
Fair value of vested stock options	14,856	56,574
Fair value of vested restricted common stock	87,733	87,167
Changes in operating assets and liabilities:
Accounts receivable	1,184,710	(74,685)
Prepaid expenses and other current assets	13,692	17,812
Prepaid royalties	(244,400)	(146,045)
Deposits and other assets	50	95
Accounts payable and accrued expenses	(374,291)	244,330
Deferred revenue	231,533	89,355
Net cash provided by operating activities	533,686	110,521
Cash flow from investing activities:
Purchase of property and equipment	(10,101)	0
Purchase of intangible assets	(5,209)	0
Net cash used in investing activities	(15,310)	0
Cash flow from financing activities:
Advance under line of credit	0	500,000
Payment under line of credit	0	(500,000)
Common stock repurchase and retirement	(26,528)	(1,756)
Net cash used in financing activities	(26,528)	(1,756)
Effect of exchange rate changes	(2,509)	2,103
Net increase (decrease) in cash and cash equivalents	489,339	110,868
Cash and cash equivalents, beginning of period	6,076,875	1,354,158
Cash and cash equivalents, end of period	6,566,214	1,465,026
Supplemental disclosures of cash flow information:
Cash paid for income taxes	13,605	11,244
Cash paid for interest	$ 3,000	$ 4,993

Organization, Nature of Busines

Organization, Nature of Business and Basis of Presentation	3 Months Ended
	Sep. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Nature of Business and Basis of Presentation	Organization, Nature of Business and Basis of Presentation Organization Research Solutions, Inc. (the “Company,” “Research Solutions,” “we,” “us” or “our”) was incorporated in the State of Nevada on November 2, 2006. On March 4, 2013, we consummated a merger with DYSC Subsidiary Corporation, our wholly-owned subsidiary, pursuant to which we, in connection with such merger, amended our Articles of Incorporation to change our name to Research Solutions, Inc. (formerly Derycz Scientific, Inc.). Research Solutions, Inc. is a publicly traded holding company with two wholly owned subsidiaries: Reprints Desk, Inc., a Delaware corporation (“Reprints Desk”) and Reprints Desk Latin America S. de R.L. de C.V, an entity organized under the laws of Mexico (“Reprints Desk Latin America”). Nature of Business We provide a cloud based software-as-a-service (“SaaS”) research intelligence platform that allows on-demand access to scientific, technical, and medical (“STM”) information for life science companies, academic institutions, and other research-intensive organizations. We provide three service offerings to our customers: Article Galaxy SaaS Platforms (“Platform(s)”), Article Galaxy Transactions (“Transactions”), and Reprints and ePrints. Platforms Our cloud-based SaaS solution consists of proprietary software and Internet-based interfaces that allow customers to initiate orders, manage transactions, obtain reporting, automate authentication, and connect seamlessly to corporate intranets. Customers can also enhance the information resources they already own or access via subscriptions or internal libraries, as well as organize workgroups to collaborate around scientific and technical information. Our Platform is deployed as a single system across our entire customer base. Customers access the Platform securely through online web interfaces and via web service APIs, which enable customers to leverage features and functionality from within proprietary and other 3rd party software systems. The Platform can also be configured to satisfy a customer’s individual preferences in areas such as user experience, business processes, and spend management. The Platform benefits from efficiencies in scalability, stability and development costs, resulting in significant advantages versus multiple instance or installed desktop software alternatives. We leverage these technical efficiencies to fuel rapid innovation and competitive advantage. Transactions Our Platform provides our customers with a single source to the universe of published STM content that includes over seventy million existing STM articles and over one million newly published STM articles each year. Our Platform allows customers to find and download in digital format STM articles that are critical to their research. In addition, it facilitates customers’ compliance with applicable copyright laws. Researchers and knowledge workers in life science and other research-intensive organizations generally require single copies of published STM journal articles for use in their research activities. They place orders with us for the articles they need and we source and electronically deliver the requested content to them generally in under an hour. This service is known in the industry as single article delivery or document delivery. We also obtain the necessary permissions from the content publisher so that our customer’s use complies with applicable copyright laws. We have arrangements with numerous content publishers that allow us to distribute their content. The majority of these publishers provide us with electronic access to their content, which allows us to electronically deliver single articles to our customers often in a matter of minutes. Even though single article delivery services are charged on a transactional basis, customer order volume tends to be consistent from month to month in part due to consistent orders of larger customers that require the implementation of our services into their work flow, subject to fluctuations due to the addition or loss of customers. Reprints and ePrints Marketing departments in life science and other research-intensive organizations generally require large quantities of printed copies of published STM journal articles called “Reprints” that are distributed to physicians and at conferences. We obtain the necessary permissions from the content publisher so that our customer’s use complies with applicable copyright laws. The majority of content publishers print their content in-house and prohibit others from printing their content; however, when not prohibited by the content publisher, we use third parties to print Reprint orders. Electronic copies, called “ePrints”, are also used for distribution through the Internet and other electronic mechanisms. We have developed proprietary ePrint software that increases the efficiency of our customers’ content purchases by transitioning from paper Reprints to electronic ePrints, and by improving compliance with applicable copyright laws and promotional regulations within the life science industry. Reprints and ePrints are charged on a transactional basis and order volume typically fluctuates from month to month based on customer marketing budgets and the existence of STM journal articles that fit customer requirements. Principles of Consolidation The accompanying financial statements are consolidated and include the accounts of the Company and its wholly-owned subsidiaries. Intercompany balances and transactions have been eliminated in consolidation. Basis of Presentation The accompanying condensed consolidated financial statements are unaudited. These unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Accordingly, these interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2016 filed with the SEC. The condensed consolidated balance sheet as of June 30, 2016 included herein was derived from the audited consolidated financial statements as of that date, but does not include all disclosures, including notes, required by GAAP. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to fairly present the Company's financial position and results of operations for the interim periods reflected. Except as noted, all adjustments contained herein are of a normal recurring nature. Results of operations for the fiscal periods presented herein are not necessarily indicative of fiscal year-end results.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Sep. 30, 2016
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2. Summary of Significant Accounting Policies The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. These estimates and assumptions include estimates for reserves of uncollectible accounts, analysis of impairments of recorded intangibles, accruals for potential liabilities and assumptions made in valuing equity instruments issued for services or acquisitions. Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of cash and cash equivalents and accounts receivable. The Company places its cash with high quality financial institutions and at times may exceed the FDIC $ 250,000 Cash denominated in Euros with a US Dollar equivalent of $ 133,840 76,793 There were no customers that accounted for greater than 10% As of September 30, September 30, 2016 2015 Customer A * 11 % Three Months Ended 2016 2015 Vendor A 17 % 17 % * Less than 10% The Company’s policy is to recognize revenue when services have been performed, risk of loss and title to the product transfers to the customer, the selling price is fixed or determinable, and collectability is reasonably assured. We generate revenue by providing three service offerings to our customers: Platforms, Transactions, and Reprints and ePrints. Platforms We charge a subscription fee that allows customers to access and utilize our SaaS platform. Revenue is recognized ratably over the term of the subscription agreement, which is typically one year, provided all other revenue recognition criteria have been met. Billings or payments received in advance of revenue recognition are recorded as deferred revenue. Transactions We charge a transactional service fee for the electronic delivery of single articles, and a corresponding copyright fee for the permitted use of the content. This service is known in the industry as single article delivery or document delivery. We recognize revenue from single article delivery services upon delivery to the customer only when the selling price is fixed or determinable, and collectability is reasonably assured. Reprints and ePrints We charge a transactional fee for each Reprint or ePrint order and are responsible for printing and delivery of Reprint orders, and the electronic delivery and, in some cases, the electronic delivery mechanism of ePrint orders. The majority of content publishers print their content in-house and prohibit others from printing their content; however, when not prohibited by the content publisher, we use third parties to print Reprint orders. We recognize revenue from reprints and ePrints services upon shipment or electronic delivery to the customer only when the selling price is fixed or determinable, and collectability is reasonably assured. Deferred Revenue Customer deposits and billings or payments received in advance of revenue recognition are recorded as deferred revenue. Platforms Cost of Platform revenue consists primarily of personnel costs of our operations team, and to a lesser extent managed hosting providers and other third-party service providers. Transactions Cost of Transaction revenue consists primarily of the respective copyright fee for the permitted use of the content, less a discount in most cases, and to a much lesser extent, personnel costs of our operations team and third-party service providers. Reprints and ePrints Cost of Reprints and ePrints revenue consists primarily of the respective copyright fee for the permitted use of the content, and to a much lesser extent, personnel costs of our operations team, shipping, and printing. The Company periodically issues stock options, warrants and restricted stock to employees and non-employees for services, in capital raising transactions, and for financing costs. The Company accounts for share-based payments under the guidance as set forth in the Share-Based Payment Topic 718 of the FASB Accounting Standards Codification, which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees, officers, directors, and consultants, including employee stock options, based on estimated fair values. The Company estimates the fair value of stock option and warrant awards to employees and directors on the date of grant using an option-pricing model, and the value of the portion of the award that is ultimately expected to vest is recognized as expense over the required service period in the Company's Statements of Operations. The Company estimates the fair value of restricted stock awards to employees and directors using the market price of the Company’s common stock on the date of grant, and the value of the portion of the award that is ultimately expected to vest is recognized as expense over the required service period in the Company's Statements of Operations. The Company accounts for share-based payments to non-employees in accordance with Topic 505 of the FASB Accounting Standards Codification, whereby the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) the date at which the necessary performance to earn the equity instruments is complete. Stock-based compensation is based on awards ultimately expected to vest and is reduced for estimated forfeitures. Forfeitures are estimated at the time of grant and revised, as necessary, in subsequent periods if actual forfeitures differ from those estimates. The accompanying consolidated financial statements are presented in United States dollars, the functional currency of the Company. Capital accounts of foreign subsidiaries are translated into US Dollars from foreign currency at their historical exchange rates when the capital transactions occurred. Assets and liabilities are translated at the exchange rate as of the balance sheet date. Income and expenditures are translated at the average exchange rate of the period. Although the majority of our revenue and costs are in US dollars, the costs of Reprints Desk Latin America are in Mexican Pesos. As a result, currency exchange fluctuations may impact our revenue and the costs of our operations. We currently do not engage in any currency hedging activities. Gains and losses from foreign currency transactions, which result from a change in exchange rates between the functional currency and the currency in which a foreign currency transaction is denominated, are included in selling, general and administrative expenses and amounted to $ 3,324 1,317 Three Months Ended Year Ended 2016 2015 2016 2015 Period end Euro : US Dollar exchange rate 1.12 1.12 1.11 1.11 Average period Euro : US Dollar exchange rate 1.12 1.11 1.11 1.20 Period end Mexican Peso : US Dollar exchange rate 0.05 0.06 0.05 0.06 Average period Mexican Peso : US Dollar exchange rate 0.05 0.06 0.06 0.07 Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period, excluding shares of unvested restricted common stock. Shares of restricted stock are included in the basic weighted average number of common shares outstanding from the time they vest. Diluted earnings per share is computed by dividing the net income applicable to common stock holders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Shares of restricted stock are included in the diluted weighted average number of common shares outstanding from the date they are granted. Potential common shares are excluded from the computation when their effect is antidilutive. At September 30, 2016 potentially dilutive securities include options to acquire 2,723,193 1,985,000 2,508,503 305,000 Basic and diluted net loss per common share is the same for the three months ended September 30, 2016 and 2015 because all stock options, warrants, and unvested restricted common stock are anti-dilutive. In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers In February 2016, the FASB issued Accounting Standards Update (ASU) No. 2016-02, Leases. ASU 2016-02 requires a lessee to record a right of use asset and a corresponding lease liability on the balance sheet for all leases with terms longer than 12 months. ASU 2016-02 is effective for all interim and annual reporting periods beginning after December 15, 2018. Early adoption is permitted. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The Company is currently evaluating the expected impact that the standard could have on its financial statements and related disclosures. Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.

Line of Credit

Line of Credit	3 Months Ended
	Sep. 30, 2016
Line of Credit Facility [Abstract]
Line of Credit	Note 3. Line of Credit The Company entered into a Loan and Security Agreement with Silicon Valley Bank (“SVB”) on July 23, 2010, which, as amended, provides for a revolving line of credit for the lesser of $ 4,000,000 80 October 31, 2017 2.25 800,000 5.75 There were no outstanding borrowings under the line as of September 30, 2016 and June 30, 2016, respectively. As of September 30, 2016 and June 30, 2016, approximately $ 2,860,000 3,390,000

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Sep. 30, 2016
Stockholders' Equity Note [Abstract]
Stockholders' Equity	Note 4. Stockholders’ Equity Stock Options In December 2007, we established the 2007 Equity Compensation Plan (the “Plan”). The Plan was approved by our board of directors and stockholders. The purpose of the Plan is to grant stock and options to our employees, directors and key consultants to purchase our common stock. On November 21, 2014, the maximum number of shares of common stock that may be issued pursuant to awards granted under the Plan (including issuance of restricted common stock) increased from 3,000,000 5,000,000 734,148 The majority of awards issued under the Plan vest immediately or over three years, with a one year cliff vesting period, and have a term of ten years. Stock-based compensation cost is measured at the grant date, based on the fair value of the awards that are ultimately expected to vest, and recognized on a straight-line basis over the requisite service period, which is generally the vesting period. All Options Vested Options Unvested Options Shares Weighted Shares Weighted Shares Weighted Outstanding at June 30, 2016 2,717,193 1.16 2,517,333 1.17 199,860 1.06 Granted 6,000 0.97 - - 6,000 0.97 Options vesting - - 25,187 1.32 (25,187) 1.32 Exercised - - - - - - Forfeited/Cancelled - - - - - - Outstanding at September 30, 2016 2,723,193 $ 1.16 2,542,520 $ 1.17 180,673 $ 1.02 The weighted average remaining contractual life of all options outstanding as of September 30, 2016 was 5.74 5.49 129,260 117,900 During the three months ended September 30, 2016, the Company granted 6,000 3,600 81.4 1.27 6 14,856 100,488 Option Exercise Price Options Outstanding Remaining Options Exercisable $0.59 8,150 9.41 - 0.60 5,000 9.36 - 0.65 6,150 8.11 4,100 0.70 225,000 9.18 225,000 0.77 59,500 7.89 48,375 0.80 16,000 8.89 16,000 0.90 25,667 8.85 19,445 0.97 6,000 9.90 - 1.00 370,890 2.49 360,933 1.02 287,000 3.82 287,000 1.05 108,445 8.65 104,223 1.07 53,898 6.04 53,898 1.09 166,165 9.65 43,750 1.10 255,000 8.75 255,000 1.15 228,000 6.36 228,000 1.20 31,414 7.64 26,178 1.25 32,000 6.38 32,000 1.30 263,000 5.43 263,000 1.50 380,000 1.31 380,000 1.75 1,067 7.33 889 1.80 169,425 6.98 169,425 1.85 24,000 6.64 24,000 1.97 1,422 7.15 1,304 Total 2,723,193 2,542,520 Warrants Number of Weighted Outstanding, June 30, 2016 1,990,000 1.25 Granted - - Exercised - - Expired/Cancelled (5,000) 3.75 Outstanding, September 30, 2016 1,985,000 $ 1.25 Exercisable, June 30, 2016 1,990,000 $ 1.25 Exercisable, September 30, 2016 1,985,000 $ 1.25 There was no intrinsic value for all warrants outstanding as of September 30, 2016, based on the fair value of the Company’s common stock on September 30, 2016. Warrant Exercise Price Warrants Remaining Warrants Exercisable $1.19 100,000 5.23 100,000 1.25 1,885,000 4.70 1,885,000 Total 1,985,000 1,985,000 Restricted Common Stock Prior to July 1, 2016, the Company issued 1,303,687 1,286,474 783,845 During the three months ended September 30, 2016, the Company issued an additional 103,638 100,529 0.97 The total fair value of restricted common stock vested during the three months ended September 30, 2016 was $ 87,733 515,785 Number of Weighted Non-vested, June 30, 2016 706,642 0.82 Granted 103,638 0.97 Vested (122,046) 0.90 Forfeited - - Non-vested, September 30, 2016 688,234 $ 0.83 Common Stock Repurchase and Retirement During the three months ended September 30, 2016, the Company repurchased 25,508 1.04 26,528

Subsequent Events

Subsequent Events	3 Months Ended
	Sep. 30, 2016
Subsequent Events [Abstract]
Subsequent Events	Note 5. Subsequent Events On November 10, 2016, the maximum number of shares of common stock that may be issued pursuant to awards granted under the 2007 Equity Compensation Plan increased from 5,000,000 to 7,000,000, as approved by our board of directors and stockholders.

Summary of Significant Accoun12

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Sep. 30, 2016
Accounting Policies [Abstract]
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates. These estimates and assumptions include estimates for reserves of uncollectible accounts, analysis of impairments of recorded intangibles, accruals for potential liabilities and assumptions made in valuing equity instruments issued for services or acquisitions.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments, which potentially subject the Company to concentrations of credit risk, consist of cash and cash equivalents and accounts receivable. The Company places its cash with high quality financial institutions and at times may exceed the FDIC $ 250,000 Cash denominated in Euros with a US Dollar equivalent of $ 133,840 76,793 There were no customers that accounted for greater than 10% As of September 30, September 30, 2016 2015 Customer A * 11 % Three Months Ended 2016 2015 Vendor A 17 % 17 % * Less than 10%
Revenue Recognition	The Company’s policy is to recognize revenue when services have been performed, risk of loss and title to the product transfers to the customer, the selling price is fixed or determinable, and collectability is reasonably assured. We generate revenue by providing three service offerings to our customers: Platforms, Transactions, and Reprints and ePrints. Platforms We charge a subscription fee that allows customers to access and utilize our SaaS platform. Revenue is recognized ratably over the term of the subscription agreement, which is typically one year, provided all other revenue recognition criteria have been met. Billings or payments received in advance of revenue recognition are recorded as deferred revenue. Transactions We charge a transactional service fee for the electronic delivery of single articles, and a corresponding copyright fee for the permitted use of the content. This service is known in the industry as single article delivery or document delivery. We recognize revenue from single article delivery services upon delivery to the customer only when the selling price is fixed or determinable, and collectability is reasonably assured. Reprints and ePrints We charge a transactional fee for each Reprint or ePrint order and are responsible for printing and delivery of Reprint orders, and the electronic delivery and, in some cases, the electronic delivery mechanism of ePrint orders. The majority of content publishers print their content in-house and prohibit others from printing their content; however, when not prohibited by the content publisher, we use third parties to print Reprint orders. We recognize revenue from reprints and ePrints services upon shipment or electronic delivery to the customer only when the selling price is fixed or determinable, and collectability is reasonably assured.
Deferred Revenue	Deferred Revenue Customer deposits and billings or payments received in advance of revenue recognition are recorded as deferred revenue.
Cost of Revenue	Cost of Revenue Platforms Cost of Platform revenue consists primarily of personnel costs of our operations team, and to a lesser extent managed hosting providers and other third-party service providers. Transactions Cost of Transaction revenue consists primarily of the respective copyright fee for the permitted use of the content, less a discount in most cases, and to a much lesser extent, personnel costs of our operations team and third-party service providers. Reprints and ePrints Cost of Reprints and ePrints revenue consists primarily of the respective copyright fee for the permitted use of the content, and to a much lesser extent, personnel costs of our operations team, shipping, and printing.
Stock-Based Compensation	Stock-Based Compensation The Company periodically issues stock options, warrants and restricted stock to employees and non-employees for services, in capital raising transactions, and for financing costs. The Company accounts for share-based payments under the guidance as set forth in the Share-Based Payment Topic 718 of the FASB Accounting Standards Codification, which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees, officers, directors, and consultants, including employee stock options, based on estimated fair values. The Company estimates the fair value of stock option and warrant awards to employees and directors on the date of grant using an option-pricing model, and the value of the portion of the award that is ultimately expected to vest is recognized as expense over the required service period in the Company's Statements of Operations. The Company estimates the fair value of restricted stock awards to employees and directors using the market price of the Company’s common stock on the date of grant, and the value of the portion of the award that is ultimately expected to vest is recognized as expense over the required service period in the Company's Statements of Operations. The Company accounts for share-based payments to non-employees in accordance with Topic 505 of the FASB Accounting Standards Codification, whereby the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) the date at which the necessary performance to earn the equity instruments is complete. Stock-based compensation is based on awards ultimately expected to vest and is reduced for estimated forfeitures. Forfeitures are estimated at the time of grant and revised, as necessary, in subsequent periods if actual forfeitures differ from those estimates.
Foreign Currency Transactions	Foreign Currency The accompanying consolidated financial statements are presented in United States dollars, the functional currency of the Company. Capital accounts of foreign subsidiaries are translated into US Dollars from foreign currency at their historical exchange rates when the capital transactions occurred. Assets and liabilities are translated at the exchange rate as of the balance sheet date. Income and expenditures are translated at the average exchange rate of the period. Although the majority of our revenue and costs are in US dollars, the costs of Reprints Desk Latin America are in Mexican Pesos. As a result, currency exchange fluctuations may impact our revenue and the costs of our operations. We currently do not engage in any currency hedging activities. Gains and losses from foreign currency transactions, which result from a change in exchange rates between the functional currency and the currency in which a foreign currency transaction is denominated, are included in selling, general and administrative expenses and amounted to $ 3,324 1,317 Three Months Ended Year Ended 2016 2015 2016 2015 Period end Euro : US Dollar exchange rate 1.12 1.12 1.11 1.11 Average period Euro : US Dollar exchange rate 1.12 1.11 1.11 1.20 Period end Mexican Peso : US Dollar exchange rate 0.05 0.06 0.05 0.06 Average period Mexican Peso : US Dollar exchange rate 0.05 0.06 0.06 0.07
Net Income (Loss) Per Share	Net Income (Loss) Per Share Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period, excluding shares of unvested restricted common stock. Shares of restricted stock are included in the basic weighted average number of common shares outstanding from the time they vest. Diluted earnings per share is computed by dividing the net income applicable to common stock holders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued, using the treasury stock method. Shares of restricted stock are included in the diluted weighted average number of common shares outstanding from the date they are granted. Potential common shares are excluded from the computation when their effect is antidilutive. At September 30, 2016 potentially dilutive securities include options to acquire 2,723,193 1,985,000 2,508,503 305,000 Basic and diluted net loss per common share is the same for the three months ended September 30, 2016 and 2015 because all stock options, warrants, and unvested restricted common stock are anti-dilutive.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers In February 2016, the FASB issued Accounting Standards Update (ASU) No. 2016-02, Leases. ASU 2016-02 requires a lessee to record a right of use asset and a corresponding lease liability on the balance sheet for all leases with terms longer than 12 months. ASU 2016-02 is effective for all interim and annual reporting periods beginning after December 15, 2018. Early adoption is permitted. A modified retrospective transition approach is required for lessees for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, with certain practical expedients available. The Company is currently evaluating the expected impact that the standard could have on its financial statements and related disclosures. Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.

Summary of Significant Accoun13

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Sep. 30, 2016
Accounting Policies [Abstract]
Schedule of Revenue by Major Customers	The following table summarizes revenue concentrations: As of September 30, September 30, 2016 2015 Customer A * 11 %
Schedule of Concentration of Risk	The following table summarizes vendor concentrations: Three Months Ended 2016 2015 Vendor A 17 % 17 % * Less than 10%
Schedule Of Foreign Currency Exchange Rate	The following table summarizes the exchange rates used: Three Months Ended Year Ended 2016 2015 2016 2015 Period end Euro : US Dollar exchange rate 1.12 1.12 1.11 1.11 Average period Euro : US Dollar exchange rate 1.12 1.11 1.11 1.20 Period end Mexican Peso : US Dollar exchange rate 0.05 0.06 0.05 0.06 Average period Mexican Peso : US Dollar exchange rate 0.05 0.06 0.06 0.07

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	3 Months Ended
	Sep. 30, 2016
Stockholders' Equity Note [Abstract]
Schedule of Share-based Compensation, Stock Options, Activity	The following table summarizes vested and unvested stock option activity: All Options Vested Options Unvested Options Shares Weighted Shares Weighted Shares Weighted Outstanding at June 30, 2016 2,717,193 1.16 2,517,333 1.17 199,860 1.06 Granted 6,000 0.97 - - 6,000 0.97 Options vesting - - 25,187 1.32 (25,187) 1.32 Exercised - - - - - - Forfeited/Cancelled - - - - - - Outstanding at September 30, 2016 2,723,193 $ 1.16 2,542,520 $ 1.17 180,673 $ 1.02
Schedule of Share-based Compensation, by Exercise Price Range	Option Exercise Price Options Outstanding Remaining Options Exercisable $0.59 8,150 9.41 - 0.60 5,000 9.36 - 0.65 6,150 8.11 4,100 0.70 225,000 9.18 225,000 0.77 59,500 7.89 48,375 0.80 16,000 8.89 16,000 0.90 25,667 8.85 19,445 0.97 6,000 9.90 - 1.00 370,890 2.49 360,933 1.02 287,000 3.82 287,000 1.05 108,445 8.65 104,223 1.07 53,898 6.04 53,898 1.09 166,165 9.65 43,750 1.10 255,000 8.75 255,000 1.15 228,000 6.36 228,000 1.20 31,414 7.64 26,178 1.25 32,000 6.38 32,000 1.30 263,000 5.43 263,000 1.50 380,000 1.31 380,000 1.75 1,067 7.33 889 1.80 169,425 6.98 169,425 1.85 24,000 6.64 24,000 1.97 1,422 7.15 1,304 Total 2,723,193 2,542,520
Schedule of Other Share-based Compensation, Activity	The following table summarizes warrant activity: Number of Weighted Outstanding, June 30, 2016 1,990,000 1.25 Granted - - Exercised - - Expired/Cancelled (5,000) 3.75 Outstanding, September 30, 2016 1,985,000 $ 1.25 Exercisable, June 30, 2016 1,990,000 $ 1.25 Exercisable, September 30, 2016 1,985,000 $ 1.25
Schedule of Stockholders' Equity Note, Warrants or Rights	Additional information regarding warrants outstanding and exercisable as of September 30, 2016 is as follows: Warrant Exercise Price Warrants Remaining Warrants Exercisable $1.19 100,000 5.23 100,000 1.25 1,885,000 4.70 1,885,000 Total 1,985,000 1,985,000
Schedule of Nonvested Restricted Stock Units Activity	The following table summarizes restricted common stock activity: Number of Weighted Non-vested, June 30, 2016 706,642 0.82 Granted 103,638 0.97 Vested (122,046) 0.90 Forfeited - - Non-vested, September 30, 2016 688,234 $ 0.83

Summary of Significant Accoun15

Summary of Significant Accounting Policies (Details)	3 Months Ended
	Sep. 30, 2016		Sep. 30, 2015
Customer Concentration Risk [Member] | Customer A [Member] | Sales Revenue, Net [Member]
Concentration Risk, Percentage		[1]	11.00%
[1]	Less than 10%

Summary of Significant Accoun16

Summary of Significant Accounting Policies (Details 1)	3 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Vendor A [Member]
Concentration Risk, Percentage	17.00%	17.00%

Summary of Significant Accoun17

Summary of Significant Accounting Policies (Details 2)	3 Months Ended		12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Euro To us Dollar [Member]
Period end exchange rate	1.12	1.12	1.11	1.11
Average period exchange rate	1.12	1.11	1.11	1.2
Mexian peso To us Dollar [Member]
Period end exchange rate	0.05	0.06	0.05	0.06
Average period exchange rate	0.05	0.06	0.06	0.07

Summary of Significant Accoun18

Summary of Significant Accounting Policies (Details Textual) - USD ($)	3 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Jun. 30, 2016
Cash, FDIC Insured Amount	$ 250,000
Foreign Currency Transaction Gain (Loss), before Tax	$ 3,324	$ 1,317
Sales Revenue, Net [Member] | Customer Concentration Risk [Member]
Concentration Risk, Benchmark Description	Less than 10%
Accounts Receivable [Member] | Customer Concentration Risk [Member]
Concentration Risk, Benchmark Description	greater than 10%
Europe Financial Institutions [Member]
Deposits	$ 133,840		$ 76,793
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	2,723,193	2,508,503
Employee Stock Option [Member] | Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	1,985,000	305,000

Line of Credit (Details Textual

Line of Credit (Details Textual) - USD ($)	1 Months Ended	3 Months Ended
	Jul. 23, 2010	Sep. 30, 2016	Jun. 30, 2016
Line of Credit Facility, Interest Rate Description		the prime rate plus 5.25%
Line of Credit Facility, Remaining Borrowing Capacity		$ 2,860,000	$ 3,390,000
Line of Credit Facility, Interest Rate at Period End		5.75%
Silicon Valley Bank [Member]
Line of Credit Facility, Amount Outstanding	$ 4,000,000
Line Of Credit Facility Expiration Date 1		Oct. 31, 2017
Debt Instrument, Basis Spread on Variable Rate		2.25%
Line Of Credit Facility Minimum Amount Outstanding During Period		$ 800,000
Debt Instrument, Covenant Description		Financial covenants include maintaining a ratio of quick assets to current liabilities of at least 0.8 to 1.0, and maintaining tangible net worth of $600,000, plus 50% of net income for the fiscal quarter ended from and after December 31, 2015, plus 50% of the dollar value of equity issuances after October 1, 2015 and the principal amount of subordinated debt.
Percentage Of Eligible Accounts Receivable On Line Of Credit	80.00%

Stockholders' Equity (Details)

Stockholders' Equity (Details)	3 Months Ended
	Sep. 30, 2016$ / sharesshares
Outstanding beginning balance Shares | shares	2,717,193
Granted Shares | shares	6,000
Options vesting Shares | shares	0
Exercised Shares | shares	0
Forfeited/Cancelled Shares | shares	0
Outstanding ending balance Shares | shares	2,723,193
Outstanding beginning balance Weighted Average Exercise Price | $ / shares	$ 1.16
Granted Weighted Average Exercise Price | $ / shares	0.97
Options vesting Weighted Average Exercise Price | $ / shares	0
Exercised Weighted Average Exercise Price | $ / shares	0
Forfeited/Cancelled Weighted Average Exercise Price | $ / shares	0
Outstanding ending balance Weighted Average Exercise Price | $ / shares	$ 1.16
Vested Options [Member]
Outstanding beginning balance Shares | shares	2,517,333
Granted Shares | shares	0
Options vesting Shares | shares	25,187
Exercised Shares | shares	0
Forfeited/Cancelled Shares | shares	0
Outstanding ending balance Shares | shares	2,542,520
Outstanding beginning balance Weighted Average Exercise Price | $ / shares	$ 1.17
Granted Weighted Average Exercise Price | $ / shares	0
Options vesting Weighted Average Exercise Price | $ / shares	1.32
Exercised Weighted Average Exercise Price | $ / shares	0
Forfeited/Cancelled Weighted Average Exercise Price | $ / shares	0
Outstanding ending balance Weighted Average Exercise Price | $ / shares	$ 1.17
Unvested Options [Member]
Outstanding beginning balance Shares | shares	199,860
Granted Shares | shares	6,000
Options vesting Shares | shares	(25,187)
Exercised Shares | shares	0
Forfeited/Cancelled Shares | shares	0
Outstanding ending balance Shares | shares	180,673
Outstanding beginning balance Weighted Average Exercise Price | $ / shares	$ 1.06
Granted Weighted Average Exercise Price | $ / shares	0.97
Options vesting Weighted Average Exercise Price | $ / shares	1.32
Exercised Weighted Average Exercise Price | $ / shares	0
Forfeited/Cancelled Weighted Average Exercise Price | $ / shares	0
Outstanding ending balance Weighted Average Exercise Price | $ / shares	$ 1.02

Stockholders' Equity (Details 1

Stockholders' Equity (Details 1) - Employee Stock Option [Member]	3 Months Ended
	Sep. 30, 2016$ / sharesshares
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	2,723,193
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	2,542,520
Range One [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	8,150
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	0
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 0.59
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	9 years 4 months 28 days
Range Two [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	5,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	0
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 0.60
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	9 years 4 months 10 days
Range Three [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	6,150
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	4,100
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 0.65
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	8 years 1 month 10 days
Range Four [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	225,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	225,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 0.70
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	9 years 2 months 5 days
Range Five [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	59,500
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	48,375
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 0.77
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	7 years 10 months 20 days
Range Six [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	16,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	16,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 0.80
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	8 years 10 months 20 days
Range Seven [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	25,667
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	19,445
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 0.90
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	8 years 10 months 6 days
Range Eight [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	6,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	0
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 0.97
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	9 years 10 months 24 days
Range Nine [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	370,890
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	360,933
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 1
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	2 years 5 months 26 days
Range Ten [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	287,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	287,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 1.02
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	3 years 9 months 25 days
Range Eleven [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	108,445
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	104,223
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 1.05
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	8 years 7 months 24 days
Range Twelve [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	53,898
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	53,898
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 1.07
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	6 years 14 days
Range Thirteen [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	166,165
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	43,750
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 1.09
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	9 years 7 months 24 days
Range Fourteen [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	255,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	255,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 1.10
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	8 years 9 months
Range Fifteen [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	228,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	228,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 1.15
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	6 years 4 months 10 days
Range Sixteen [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	31,414
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	26,178
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 1.20
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	7 years 7 months 20 days
Range Seventeen [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	32,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	32,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 1.25
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	6 years 4 months 17 days
Range Eighteen [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	263,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	263,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 1.30
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	5 years 5 months 5 days
Range Nineteen [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	380,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	380,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 1.50
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	1 year 3 months 22 days
Range Twenty [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	1,067
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	889
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 1.75
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	7 years 3 months 29 days
Range Twenty One [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	169,425
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	169,425
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 1.80
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	6 years 11 months 23 days
Range Twenty Two [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	24,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	24,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 1.85
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	6 years 7 months 20 days
Range Twenty Three [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options, Beginning Balance	1,422
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options, Beginning Balance	1,304
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price, Beginning of Period | $ / shares	$ 1.97
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	7 years 1 month 24 days

Stockholders' Equity (Details 2

Stockholders' Equity (Details 2) - Warrant [Member] - $ / shares	3 Months Ended
	Sep. 30, 2016	Sep. 30, 2016	Jun. 30, 2016
Non-vested, Beginning balance	1,985,000
Granted Number of Warrants	0
Exercised Number Warrants	0
Expired/Cancelled Number of Warrants	(5,000)
Non-vested, Ending balance	1,990,000
Exercisable Number of Warrants		1,985,000	1,990,000
Outstanding, Beginning balance Weighted Average Exercise Price	$ 1.25
Granted Weighted Average Exercise Price	0
Exercised Weighted Average Exercise Price	0
Expired Weighted Average Expired Price	3.75
Outstanding, Ending balance Weighted Average Exercise Price	1.25
Exercisable, Weighted Average Exercise Price	$ 1.25	$ 1.25	$ 1.25

Stockholders' Equity (Details 3

Stockholders' Equity (Details 3) - Warrant [Member] - $ / shares	3 Months Ended
	Sep. 30, 2016	Jun. 30, 2016
Warrant Exercise Price		$ 1.25
Warrants Outstanding	1,990,000	1,985,000
Warrants Exercisable	1,985,000	1,990,000
Range One [Member]
Warrant Exercise Price	$ 1.19
Warrants Outstanding	100,000
Warrants Outstanding Remaining Contractual Life (in years)	5 years 2 months 23 days
Warrants Exercisable	100,000
Range Two [Member]
Warrant Exercise Price	$ 1.25
Warrants Outstanding	1,885,000
Warrants Outstanding Remaining Contractual Life (in years)	4 years 8 months 12 days
Warrants Exercisable	1,885,000

Stockholders' Equity (Details 4

Stockholders' Equity (Details 4) - Restricted Common Stock	3 Months Ended
	Sep. 30, 2016$ / sharesshares
Non-vested, Beginning balance | shares	706,642
Granted Number of shares | shares	103,638
Vested, Number of shares | shares	(122,046)
Forfeited, Number of shares | shares	0
Non-vested, Ending balance | shares	688,234
Non-Vested, Beginning balance weighted averge grant date fair value | $ / shares	$ 0.82
Granted Weighted Average Grant date Fair Value | $ / shares	0.97
Vested Weighted Average Grant date Fair Value | $ / shares	0.9
Forfeited Weighted Average Grant date Fair Value | $ / shares	0
Non-vested,Ending Balance Weighted Average Grant date Fair Value | $ / shares	$ 0.83

Stockholders' Equity (Details T

Stockholders' Equity (Details Textual) - USD ($)	3 Months Ended		12 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Jun. 30, 2016	Nov. 21, 2014
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	734,148
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	5 years 8 months 26 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	5 years 5 months 26 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	$ 129,260
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value	117,900
Stock or Unit Option Plan Expense	14,856	$ 56,574
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options	100,488
Stock Issued During Period, Value, Restricted Stock Award, Gross	87,733
Stock Repurchased During Period, Value	$ 26,528
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	6,000
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate	81.40%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	1.27%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	6 years
Proceeds from Stock Options Exercised	$ 14,856
Director [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value	3,600
Restricted Stock [Member]
Stock or Unit Option Plan Expense			$ 783,845
Stock Issued During Period, Shares, Restricted Stock Award, Gross			1,303,687
Stock Issued During Period, Value, Restricted Stock Award, Gross			$ 1,286,474
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options	$ 515,785
Restricted Stock [Member] | Employees [Member]
Stock Issued During Period, Shares, Restricted Stock Award, Gross	103,638
Stock Issued During Period, Value, Restricted Stock Award, Gross	$ 100,529
Sale of Stock, Price Per Share	$ 0.97
Repurchase Program [Member]
Stock Repurchased During Period, Shares	25,508
Treasury Stock Acquired, Average Cost Per Share	$ 1.04
Stock Repurchased During Period, Value	$ 26,528
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant				3,000,000
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant				5,000,000

Subsequent Events (Details Text

Subsequent Events (Details Textual) - shares	Nov. 10, 2016	Nov. 09, 2016	Sep. 30, 2016
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant			734,148
Subsequent Event [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	7,000,000	5,000,000